Sheldon L. Koenig
2019 - Portola Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $169,866 |
---|---|
Option Awards | $1,977,150 |
Salary | $419,423 |
Stock Awards | $677,500 |
Other | $216,601 |
Total | $3,460,540 |
Koenig received $2M in option awards, accounting for 57% of the total pay in 2019.
Koenig also received $169.9K in non-equity incentive plan, $419.4K in salary, $677.5K in stock awards and $216.6K in other compensation.
Rankings
In 2019, Sheldon L. Koenig's compensation ranked 3,524th out of 13,971 executives tracked by ExecPay. In other words, Koenig earned more than 74.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,524 | 75th |
Manufacturing | 1,275 | 78th |
Chemicals And Allied Products | 440 | 80th |
Drugs | 367 | 81st |
Pharmaceutical Preparations | 277 | 80th |
Pay ratio
Sheldon L. Koenig's Pay | $3,460,540 |
---|---|
Median Employee's Pay | $291,408 |
Pay Ratio | 12to 1 |
In 2019, the annual total compensation of Sheldon L. Koenig was $3,460,540.
The annual total compensation of the median employee at Portola Pharmaceuticals was $291,408.
The ratio of Sheldon L. Koenig's pay to the pay of median employee was therefore 12 to one.
Koenig's colleagues
We found four more compensation records of executives who worked with Sheldon L. Koenig at Portola Pharmaceuticals in 2019.
2019
Scott Garland
Portola Pharmaceuticals
Chief Executive Officer
2019
Ernie Meyer
Portola Pharmaceuticals
Chief Human Resources Officer
2019
John Moriarty
Portola Pharmaceuticals
General Counsel
2019
Mardi Dier
Portola Pharmaceuticals
Executive Vice President, Chief Financial and Business Officer
News
April 11, 2024
April 13, 2023
April 14, 2022
April 20, 2020